Cite Filings / KROS / 0001104659-25-034310

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Keros Therapeutics, Inc. Filed 2025-04-11 Acc 0001104659-25-034310

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-04-18 SCHEDULE 13D/A Beneficial Ownership Report
2025-04-11 4 10% owner bought 934,258 shares at an average $10.13 ($9,464,512)
2025-04-11 3 Initial Statement of Ownership
2025-04-11 SCHEDULE 13D Beneficial Ownership Report
2025-04-10 8-A12B Registration of Securities
2025-04-10 8-K Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
2025-04-07 4 CHIEF EXECUTIVE OFFICER acquired 49,367 shares (option exercise)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…